A Meta-Analysis of Proton Pump Inhibitor Use and the Risk of Acute Kidney Injury: Geographical Differences and Associated Factors
- PMID: 37048551
- PMCID: PMC10095047
- DOI: 10.3390/jcm12072467
A Meta-Analysis of Proton Pump Inhibitor Use and the Risk of Acute Kidney Injury: Geographical Differences and Associated Factors
Abstract
Proton pump inhibitors (PPIs) are widely prescribed in medical practice for the treatment of several gastrointestinal disorders. Previous epidemiology studies have reported the association between PPI use and the risk of AKI, although the magnitude of the association between PPIs and the risk of acute kidney injury (AKI) remains uncertain. Therefore, we conducted a meta-analysis to determine the relationship between PPI therapy and the risk of AKI. We systematically searched for relevant articles published before January 2023 on PubMed, Scopus, and Web of Science. In addition, we conducted a manual search of the bibliographies of potential articles. Two independent reviewers examined the appropriateness of all studies for inclusion. We pooled studies that compared the risk of AKI with PPI against their control using a random effect model. The search criteria based on PRISMA guidelines yielded 568 articles. Twelve observational studies included 2,492,125 individuals. The pooled adjusted RR demonstrated a significant positive association between PPI therapy and the risk of AKI (adjusted RR 1.75, 95% CI: 1.40-2.19, p < 0.001), and it was consistent across subgroups. A visual presentation of the funnel plot and Egger's regression test showed no evidence of publication bias. Our meta-analysis indicated that persons using PPIs exhibited an increased risk of AKI. North American individuals had a higher risk of AKI compared to Asian and European individuals. However, the pooled effect from observational studies cannot clarify whether the observed association is a causal effect or the result of some unmeasured confounding factors. Hence, the biological mechanisms underlying this association are still unclear and require further research.
Keywords: acute kidney injury; chronic kidney disease; meta-analysis; proton pump inhibitor.
Conflict of interest statement
The authors declare no conflict of interest.
Figures



Similar articles
-
Proton-pump inhibitors use, and risk of acute kidney injury: a meta-analysis of observational studies.Drug Des Devel Ther. 2017 Apr 24;11:1291-1299. doi: 10.2147/DDDT.S130568. eCollection 2017. Drug Des Devel Ther. 2017. PMID: 28479851 Free PMC article.
-
Use of proton pump inhibitors and macrolide antibiotics and risk of acute kidney injury: a self-controlled case series study.BMC Nephrol. 2022 Nov 30;23(1):383. doi: 10.1186/s12882-022-03008-x. BMC Nephrol. 2022. PMID: 36451129 Free PMC article.
-
Proton Pump Inhibitors and Risk of Chronic Kidney Disease: Evidence from Observational Studies.J Clin Med. 2023 Mar 15;12(6):2262. doi: 10.3390/jcm12062262. J Clin Med. 2023. PMID: 36983271 Free PMC article.
-
The association between proton pump inhibitor use and the risk of adverse kidney outcomes: a systematic review and meta-analysis.Nephrol Dial Transplant. 2018 Feb 1;33(2):331-342. doi: 10.1093/ndt/gfw470. Nephrol Dial Transplant. 2018. PMID: 28339835
-
Meta-analysis: proton pump inhibitors moderately increase the risk of small intestinal bacterial overgrowth.J Gastroenterol. 2018 Jan;53(1):27-36. doi: 10.1007/s00535-017-1371-9. Epub 2017 Aug 2. J Gastroenterol. 2018. PMID: 28770351 Review.
Cited by
-
[Optimal Use of Proton Pump Inhibitors and Potassium-competitive Acid Blockers].Korean J Helicobacter Up Gastrointest Res. 2023 Sep;23(3):180-187. doi: 10.7704/kjhugr.2023.0034. Epub 2023 Sep 8. Korean J Helicobacter Up Gastrointest Res. 2023. PMID: 40502667 Free PMC article. Review. Korean.
-
Celecoxib has less aggravating effect on cisplatin-induced nephrotoxicity in comparison with non-selective cyclooxygenase inhibitors: a retrospective multi-institutional study.Int J Clin Oncol. 2025 Jul 7. doi: 10.1007/s10147-025-02810-5. Online ahead of print. Int J Clin Oncol. 2025. PMID: 40622478
-
Artificial Intelligence in Kidney Disease: A Comprehensive Study and Directions for Future Research.Diagnostics (Basel). 2024 Feb 12;14(4):397. doi: 10.3390/diagnostics14040397. Diagnostics (Basel). 2024. PMID: 38396436 Free PMC article. Review.
-
Association between preoperative proton pump inhibitor use and postoperative acute kidney injury in patients undergoing major surgery.Ren Fail. 2024 Dec;46(2):2379596. doi: 10.1080/0886022X.2024.2379596. Epub 2024 Aug 4. Ren Fail. 2024. PMID: 39099235 Free PMC article.
-
The Assessment of the Association of Proton Pump Inhibitor Usage with Chronic Kidney Disease Progression through a Process Mining Approach.Biomedicines. 2024 Jun 19;12(6):1362. doi: 10.3390/biomedicines12061362. Biomedicines. 2024. PMID: 38927569 Free PMC article.
References
-
- Namazzi R., Batte A., Opoka R.O., Bangirana P., Schwaderer A.L., Berrens Z., Datta D., Goings M., Ssenkusu J.M., Goldstein S.L., et al. Acute kidney injury, persistent kidney disease, and post-discharge morbidity and mortality in severe malaria in children: A prospective cohort study. EClinicalMedicine. 2022;44:101292. doi: 10.1016/j.eclinm.2022.101292. - DOI - PMC - PubMed
LinkOut - more resources
Full Text Sources